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The Friend virus complex,  FV, ~ induces  erythroleukemia in  susceptible  mice.  The 
disease  is characterized by proliferation of hematopoietm stem cells in the splenic red 
pulp, immunosuppression, massive splenomegaly, and death (1-3). Our previous reports 
(4, 5) on the spontaneous regression of erythroleukemia have contrasted the response of 
mice to two strains of FV. Both the conventional and the regressing virus strain, CFV 
and RFV, respectively, cause identical erythroleukemia, but only the disease caused by 
RFV spontaneously regresses 
Adult  mice  infected  with  RFV  develop  leukemia  within  2  wk.  Regression  occurs 
between 4 and 8 wk after virus inoculation and is characterized by the return  of the 
spleen to normal weight and histology, a marked decrease in the proliferation of infec- 
tious  RFV,  a  marked  increase  in host survival,  the  appearance  of humoral immune 
response to the virus, and the restoration to normal or more often to increased numbers of 
immunologically competent cells in the spleen (6-9). 
Subsequent studies (10), which suggested an immunological basis for regression, led to 
an evaluation of potential interactions between RFV and CFV. Inoculation of CFV mixed 
with RFV caused leukemia that regressed (11). A consistent feature of  this effect was that 
the titer of RFV which caused regression of CFV leukemia was 10-100-fold greater than 
the minimum dose of RFV that itself induced erythroleukemla. 
It has been shown that the FV consists of a spleen focus-forming virus (SFFV) 
responsible for the erythroleukemia,  and a  murine leukemia virus (MuLV-F). 
MuLV-F acts as a  helper for both the formation of foci of erythroblasts in the 
spleen  by  defective  SFFV  and  for  the  development  of  erythroleukemia  by 
supplying factors necessary for SFFV maturation (12-14). 
Helper activity is present in stocks of FV at dilutions 100-fold or more greater 
than the  SFFV titer  (15).  The observation that the  induction of regression of 
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CFV-induced leukemia by subleukemogenic doses of RFV could be correlated 
with  this  helper  activity  suggested  that  the  regressability  of  RFV-induced 
leukemia might be a function of its helper (MuLV) component. 
In this report, we present evidence that demonstrates that the helper MuLV 
in RFV is responsible for the regression of RFV-induced leukemia. 
Materials and Methods 
Vzruses.  Cell-free virus stocks were prepared from spleens of leukemic mice (20% wt/vol in 
phosphate-buffered sahne  [PBS]) as  previously described  (16)  and stored in sealed ampules at 
-70°C  RFV and CFV were maintained by serial passage m  randombred Swiss/ICR and NIH/ 
Swiss mice, respectively. N-tropic FV (FV-N), B-tropic FV (FV-B), and N and NB-tropic MuLV-F 
helper viruses were generously supplied by Dr. R. J. Eckner, Boston University Medical School, 
Boston, Mass. FV-N and N-tropic MuLV-F were maintained by passage in inbred N/PLCR Fv-l" 
adult and newborn mice, respectively  FV-B and NB-tropic MuLV-F were maintained by passage 
in adult and newborn BALB/c Fv-1 ~ mice, respectively. The MuLV helper component of FV-B is B- 
tropic Tennant MuLV (17).  NB-tropic MuLV-F was derived by serial passage of N-tropic MuLV-F 
in newborn BALB/c FV-1  b mice (Dr  R.  J  Eckner, personal communication)  NB-tropic Friend 
virus  complex  (FV-NB)  was  generously  supplied  by  Dr  P.  J.  Dawson,  Umversity of Oregon 
Health Sciences Center, Portland, Oreg  and was maintained by passage in adult BALB/c FV-1 b 
mice. MuLV-RF was derived from RFV by dilution passage m Swlss/ICR mice and was maintained 
by passage in newborn Swiss/ICR. 
Mice.  Randombred  Swiss/ICR  and  inbred  BALB/c  mice  were  from  our  own  colony.  Ran- 
dombred NIH Swms and inbred N/PLCR mine were obtained through the courtesy of the Veteri- 
nary Resources Branch, D~vislon of Research Servmes, National Institutes of Health and subse- 
quently bred in our own laboratory  Mice were checked biweekly for leukemia and regresmon by 
spleen palpation  We have previously shown that spleen weight determined by palpation is an 
accurate indicator of leukemic status (4, 9,  16). 
Cell Culture  Mouse embryo fibroblast cultures were prepared from trypsinized 11- to 13-day- 
old embryos and grown m  Dulbecco's modified Eagle's medmm containing 15% calf serum. 
Virus Tltratmn.  The XC plaque assay (18) was done in 16-mm multiwell tmsue culture trays 
(Costar, Cambridge, Mass.) using six wells/virus dilution in a manner similar to that described by 
Croker  et  al  (19)  Titers  were  calculated  as  either 50%  infectious end  points  for  XC  plaque 
formation and expressed in IDso/ml or from the number of individual plaques and expressed in 
plaque-forming units (PFU)/ml. All wrus t~ters are the mean of at least three determinations. 
The spleen focus assay was done as described by Axelrad and Steeves (20), except that mice 
were inoculated 1 v. with 0.2 ml of virus suspension. Virus tlters were calculated from the mean 
number of superficial macroscopic foci per spleen after fixation in Bouin's fluid and are expressed 
in focus-forming umts (FFU)/ml. 
The helper virus assay was done as described by Steeves et al.  (15).  N/PLCR Fv-l" mice were 
inoculated i.v  with a  constant dilution of FV-B mixed with an equal volume of potential helper 
MuLV. Virus titers were obtained in helper units (HU) by subtracting the FFU tlter of FV-B alone 
from that obtained with the virus mixture.  One HU is defined as that amount of helper MuLV 
which increases the titer of SFFV by one FFU. 
V~rus Pseudotypes.  MuLV-F pseudotypes of SFFV were prepared using the helper wrus assay 
except that foci were counted on only half of the spleen while the other half was weighed and 
homogenized in a volume of PBS to give a  10% wt/vol suspension. The suspension was centrifuged 
to remove cells, and 0.2 ml of a 1.2 or 1:4 dilutmn of the supernate was inoculated LV. into N/PLCR 
Fv-l"  mice  Enlarged  spleens  from  mice  with  erythroleukemia  were  used  to  prepare  cell-free 
pseudotype virus stocks (20% wt/vol in PBS) as described above. 
Results 
Tropism of RFV and CFV.  Our previous experiments  (11) suggested that 
the regressability of RFV-induced leukemia might be due to the helper (MuLV) 
component of the complex.  Since the tropism of FV is conferred by its helper 596  REGRESSION  OF  ERYTHROLEUKEMIA 
virus,  we determined  the  tropism  of RFV  and  CFV by analysis  of the  dose- 
response patterns for formation of spleen foci in mice which differed at the Fv-1 
gene  locus.  Fig.  1  illustrates  the  dose-response  curves  for  RFV  and  CFV, 
compared with those obtained using control N, B, or NB-tropic viruses. 
Alleles of the mouse Fv-1  gene restrict the ability of MuLV-F to help SFFV 
form spleen foci. N-tropic FV is restricted by the Fv-1 b allele, B-tropic FV by the 
Fv-1" allele. NB-tropic virus is not sensitive to restriction by either allele of Fv-1 
(21).  This  effect of Fv-1  on  the  formation  of spleen  foci  is  indicated  by an 
apparent  decrease in  virus titer  and/or  an  increase  in  the  slope of the  dose- 
response curve (12,  17, 22). 
The estimated titer  of RFV was proportional  to virus dose at each dilution 
which gave countable numbers of foci. This pattern is the same as that seen with 
control  FV-NB,  suggesting  that  RFV  is  NB-tropic.  All  N  or  B-tropic  FV's 
assayed in Fv-1  incompatible mice were restricted in their ability to form spleen 
foci as measured by both final titer and the slope of their dose-response curves. 
The dose-response pattern caused by CFV is decreased at its SFFV dilution end 
point  in Fv-1 ~ but not in Fv-l"  mice,  suggesting  that  its  helper  MuLV is N- 
tropic. 
We confirmed the tropism of RFV and CFV by XC plaque assay (Table I). NB- 
tropic RFV produced XC plaques equally well regardless of the Fv-1 type of the 
test cells. CFV demonstrated N tropism with greatly decreased titers in n/b and 
b/b cells compared to the titer in n/n cells. The N/B ratio, which measures the 
degree to which the viruses demonstrated tropism, indicated that the N tropism 
of CFV is not as pronounced as in control N  or B-tropic FV. 
Fv-1  Type  of Swiss/ICR  Mice.  Stocks  of RFV  are  regularly  obtained  by 
passage  through  Swiss/ICR  mice  in  which  regression  has  been  extensively 
characterized  (3,  4) and  which serve as our standard  regressor mouse strain. 
When we attempted to determine their Fv-1  genotype by XC plaque test,  we 
observed that only FV-NB caused XC plaques in embryo cell pools derived from 
these Swiss/ICR mice. On occasion, plaques did appear after infection with FV- 
N  or FV-B,  but their  numbers  were not proportional  to  virus dilution.  This 
suggested that Swiss/ICR mice might be heterozygous at the Fv-1 gene locus. To 
test  this  possibility,  we  determined  the  Fv-1  type  of individual  Swiss/ICR 
embryos in XC plaque test using control N, B, or NB-tropic FV's. In prelimi- 
nary experiments, with cells of known Fv-1 type, we determined the dose of FV- 
N or FV-B which gave confluent XC plaques in compatible, and no XC plaques 
in Fv-1  incompatible cells.  Cells from each embryo were infected in duplicate 
with each virus and scored for the presence or absence of XC plaques. The data 
are summarized in Table II. 
Cells from embryos in which FV-N and FV-NB, but not FV-B, caused plaques 
are Fv-l"~", those in which Fv-B and FV-NB, but not Fv-N, caused plaques are 
Fv-1 ~b,  and those in  which only FV-NB caused plaques are Fv-1 ''/b. The data 
demonstrate  that  the parents  of the mice tested were Fv-1  heterozygotes and 
indicates that individuals in randomly chosen groups of Swiss/ICR mice possess 
either n/n, n/b, or b/b Fv-1  alleles in about the expected proportions  (1:2:1). 
To  confirm  their Fv-1  genotype,  Swiss/ICR mice  were inoculated  with the 
control FV's and  observed for leukemia  development  (Table III).  Each of the 
mouse strains of known Fv-1  type showed the expected incidence of leukemia. ..J 
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FIG  I.  Spleen  focus  assays of  RFV (A),  CFV (1),  FV-N (@),  FV-B (©),  and FV-NB ([3)  m 
Fv-l"" (---)  andFv-1 ~b (  - )  type mice Each  data  point  is  the  average  of  six  mice  per  group. 
TABLE  I 
Tropism of RFV and CFV in XC Plaque Assay 
Test cells 
Virus  N/B* ratio 
n/n  n/b  b/b 
FV-N  3.4§  <1 0  <1.0  <250 
FV-NB  4.4  4.7  4.8  0.5 
FV-B  <1.0  <1.0  5.3  <0.0001 
RFV  4.4  4.1  4.3  0.9 
CFV  4.2  3.1  2.9  20.0 
* Fv-1 genotype. 
$ Titer in Fv-l"J"/titer m Fv-1  b~b test cells 
§ Mean-logjo ID5o/ml. 
The pattern of leukemia incidence in Swiss/ICR suggested that these mice were 
heterozygous at the Fv-1 gene locus. NB-tropic RFV was infectious for all of the 
mouse strains tested. N-tropic CFV was also infectious for all of the mouse types 
due to the high virus dose used and the degree to which CFV demonstrates N 598  REGRESSION  OF  ERYTHROLEUKEMIA 
TABLE II 
Determination  of Fv-1 Type of Swiss/ICR Mzce by XC Plaque Assay 
Control  Response of individual Swlss/ICR 
embryos 
Test virus  No  observed 
Cell Fv-1  Ratio 
Genotype  N  NB  B  No  tested 
n/n  +*  +  -  7/27  (25.9)$  1 0 
n/b  -  +  -  12/27  (44.4)  1 7 
b/b  -  +  +  8/27  (29 6)  1.1 
* Infectivity in XC plaque test 
$ Percent responding 
TABLE III 
Effect of Host Strain and Virus Tropism  on Leukemm Development and Regression 
Host stram 
Virus  Fv-l"  Fv-1 t'  Fv-1  n,b,n/b 
NIH/Swlss  N/PLCR  BALB/c  Swlss/ICR 
FV-N  29/30  (0)*  18/19  (0)  0/25  9/40  (0) 
FV-NB  20/20  (0)  20/20  (0)  20/20  (0)  17/17  (1) 
FV-B  0/20  0/19  27/27  (0)  6/30  (0) 
RFV  30/30  (4)  20/20  (9)  20/20  (0)  77/77  (40) 
CFV  20/20  (0)  20/20  (0)  20/20  (0)  20/20  (0) 
* Number m  parentheses is number of mice m  which erythroleukemia regressed 
tropism as seen in XC or spleen focus titration (see above). These mice were also 
observed for regression. Leukemia regressed in only those animals infected with 
NB-tropic RFV or in Swiss/ICR mice infected with FV-NB.  Leukemia did not 
regress in BALB/c mice in accord with our previous results (23). 
Effect  of Passage  of CFV ~n  Swiss/ICR  M~ce.  The tropism of FV  can be 
changed by forced passage in mice that possess at least one Fv-1  incompatible 
allele  (17, 22). We  determined whether passage  of CFV in  Swiss/ICR would 
change its tropism and whether this would result in a virus strain which causes 
a regressing leukemia. After one passage in Swiss/ICR mice, the previously N- 
tropic CFV became NB-tropic  (Table IV) and induced a  leukemia that subse- 
quently regressed. A second passage in Swiss/ICR still yielded regression and 
NB-tropic virus.  After this second passage  in Swiss/ICR mice, the virus was 
passaged back through NIH/Swiss mice  (Fv-l"") and after five passages the 
virus remained NB-tropic, as determined by XC test, and the leukemia that it 
induced retained its ability to spontaneously regress. 
Effect of Ri-MuLV on Regression.  Since the regressing and nonregressing 
virus  differ in their MuLV component,  we  determined whether altering the 
quantity or type of MuLV in RFV would affect regression. For this purpose we 
used various doses of Ri-MuLV (16) mixed with a constant dose of RFV (Table 
V). In experiment I, a 500-fold excess of Ri-MuLV caused a marked decrease in DIETZ,  FOUCHEY,  LONGLEY,  RICH,  AND  FURMANSKI 
TABLE  IV 
Effect of V~rus Passage ~n Swtss M~ce on Regression  and Tropism 
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Virus 
No.  re- 
Passage history  gressed 
Mouse strain (no. of passages) 
No.  leu- 
kemic* 
N/B 
raho:~  Tropism 
RFV 
CFV 
Sw§ (8)  37/82  0.86  NB 
NS~' (5)  0/20  20.0  N 
NSw (5) -* Sw (1)  4/20  0.91  N  ~  NB 
NSw (5) --* Sw (2)  20/48  1.2  NB 
NSw (5) -* Sw (2) --* NSw  14/25  0.96  NB 
* Virus passage  lines were  tested for erythroleukemia reduction and regression in Swiss/ICR 
mice. 
See footnote Table I 
§ Sw is the Swlss/ICR mouse strain. 
** NSw is the NIH/Swiss mouse strain. 
TABLE  V 
Effect of Ri-MuLV on Leukemm Regression 
Relative dose*  No  erythroleu- 
kemic 
RFV  Ri-MuLV  NLT§  No.  inoculated 
Percent 
regressed$ 
Expt I 
Expt II 
1  -  -  77/85  50 
1  0.0~ I  -  39/43  46 
1  500  -  60/63  8 
-  500  -  0/10  - 
1  -  500¶  14/15  42 
1  -  120/160  56 
1  0.05  10/15  50 
1  5  12/15  33 
1  500  18/20  6 
-  500  0/15  - 
* R1-MuLV PFU/RFV FFU. Each group received a constant dose of RFV mixed with various doses 
of Ri-MuLv. 
$ No.  regressed/no, leukemic  x  100. 
§ 20% wt/vol supernate of normal lymphoid tissue homogenate from Swiss/ICR mice. 
~t Ri-MuLV PFU/RFV FFU. 
¶ RFV was mixed with a  dilution of NLT which was the same as the dilution of Ri-MuLV stock 
virus whmh gave RffMuLV PFU/RFV FFU equal to 500. 
the  incidence  of regression.  Normal  lymphoid  tissue  homogenate  or  a  20-fold 
lower  dose of Ri-MuLV  did not  affect regression.  In experiment  II,  in which  we 
used  a  10-fold  lower  dose  of RFV,  increasing  amounts  of Ri-MuLV  caused  a 
proportional  decrease  in leukemia  regressions  and  an  increase  in the  incidence 
of leukemia. 
Isolation  and  Properties  of MuLV-RF.  To  examine  the  properties  of  the 
MuLV  component  of RFV  associated  with  leukemia  regression,  we  isolated  the 
helper  MuLV  from  the  RFV  complex.  Helper  MuLV's  have  been  obtained  from 600  REGRESSION  OF  ERYTHROLEUKEMIA 
FV by sequential passage in rats or in genetically resistant mice or by end point 
dilution passage in susceptible mice (13,  24,  25).  To avoid possible changes in 
virus genetic information or in tropism due to passage in heterologous hosts or 
resistant mice (26, 22), we employed end point dilution passage to isolate helper 
MuLV's from FV. 
Adult  Swiss/ICR mice  were infected with  10-fold dilutions  of RFV and  ob- 
served for leukemia development.  2 of 10 mice infected with a  103 dilution  of 
RFV developed erythroleukemia  within  14 days post-virus inoculation.  At 90 
days post-inoculation,  one mouse that had previously been negative developed 
splenomegaly with enlarged  lymph nodes and thymus.  Examination  of histo- 
logic sections of lymph nodes, thymus, and spleen showed lymphoblast prolifera- 
tion in each of these organs and was indicative of lymphocytic leukemia. Lymph 
node  and  thymic tissue  were used to begin  a  virus passage  line  in  newborn 
Swiss/ICR  mice.  Within  3-5  too,  the  mice  developed  splenomegaly  with  or 
without gross signs of thymus and lymph node involvement.  At 229 days post- 
inoculation,  the  six  mice  still  alive had  enlarged  spleens  (710-3,250  mg)  and 
lymph  nodes,  and  one  of these  animals  had  an  enlarged  thymus  (325  mg). 
Histopathologic examination of leukemic tissue from these mice confirmed that 
each had developed lymphocytic leukemia. 
The  lymphocytic leukemia-inducing  component isolated from RFV,  MuLV- 
RF, contains no SFFV activity as determined by spleen focus assay (Table VI). 
This virus, like the parental RFV, is NB-tropic by XC plaque assays. It is known 
that  MuLV  derived from  FV can  help  defective SFFV's  make  spleen foci in 
genetically  restrictive  mice  ~15). MuLV titers  are  measured  in  HU and  NB- 
tropic MuLV-RF contained at least 104 HU of activity for the SFFV in FV-B as 
determined in N/PLCR Fv-1" mice. Additional characteristics of MuLV-RF and 
the leukemia induced by it will be described in a future report. It is of interest to 
note that the lymphocytic leukemia caused by MuLV-RF itself spontaneously 
regresses. 
The effect of MuLV-RF on nonregressing,  CFV leukemia is shown in Table 
VII.  MuLV-RF,  when  mixed  with  CFV  and  inoculated  into  adult  Swiss/ICR 
mice, caused the regression of CFV-induced erythroleukemia. 
Preparation and Properties of MuLV/RF Pseudotypes of SFFV.  We deter- 
mined the specificity of the effect of MuLV-RF on nonregressing erythroleuke- 
mia by preparing several MuLV pseudotypes of SFFV and testing their ability 
to  induce  leukemia  that  would regress.  Pseudotype preparation  was  accom- 
plished by modification of the helper virus assay in N/PLCR Fv-1  ..... mice. The 
SFFV in FV-B was rescued by NB or N-tropic helper MuLV-F (Table VIII). FV- 
B alone at a 1:40 dilution caused few spleen foci; each of the helper MuLV's used 
lacked detectable SFFV and therefore could not induce spleen foci. One half of 
each spleen from mice inoculated with FV-B alone or FV-B plus helper MuLV 
was used to prepare  a  10% wt/vol cell-free extract  which was inoculated into 
susceptible Fv-1  ..... mice to prepare stocks of pseudotype virus (Table IX). 
The  extracts  prepared  from  spleens  of mice  inoculated  with  both  viruses 
readily induced erythroleukemia within  10 days post-inoculation.  In contrast, 
the spleen extract from mice inoculated with FV-B alone did not cause erythro- 
leukemia,  even after a  180-day observation period. To confirm that FV pseudo- 
types  had  actually  been  prepared,  the  tropism  of each  of the  virus  stocks DIETZ,  FOUCHEY,  LONGLEY,  RICH~  AND  FURMANSKI 
TABLE  VI 
Properties of MuLV-RF 
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XC titer 
SFFV titer*  Tropism  Helper unit titer 
n/n$  n/b  b/b 
0  4 3§  4.2  4 5  NB  4.1  -+ 0.T 
* In FFU. 
:~  Fv-1 genotype of  test  cells. 
§ Mean -loglo ID~o/ml. 
"  loglo;  one HU  is the quantlty of MuLV-RF  that will  increase the SFFV  titer  by one FFU  in 
genehcally restrictive  mice. 
TABLE  VII 
Effect of MuLV-RF on CFV Leukemia 
No.  erythroleukemlc 
Virus  Percent regressed$ 
No.  inoculated* 
CFV  9/10  0 
RFV  10/10  70 
CFV  +  MuLV-RF  30/30  30 
MuLV-RF  0/20  - 
* Observation period was 90 days 
No.  regressed/no  leukemic  ×  100. 
TABLE  VIII 
Productmn of MuLV Pseudotypes of SFFV in N/PLCR Fv-l" M~ce 
Virus lnoculum 
FV  Helper MuLV  + 
1:40  1:10 
MuLV tropism  No.  of foci per spleen 
FV-B  MuLV-RF  NB  90, 30, 30, 38, 18, 28, 24, 20, 26 
FV-B  MuLV-F  NB  14, 76, 54 
FV-B  MuLV-F  N  36, 50, 76, 48 
FV-B  -  B  0,  1,4,  i, 0, 0,  1,0,0 
0,  0,  1,  1,0,  0,0 
MuLV-RF  NB  0, 0, 0, 0, 0, 0, 0 
MuLV-F  NB  0, 0,  0,  0 
MuLV-F  N  0, 0, 0, 0 
obtained from leukemic mice in Table IX was determined by XC plaque assay. 
In each case, the original FV-B had acquired the tropism of the helper MuLV 
used in rescue. 
Swiss/ICR mice were inoculated with each of the pseudotype virus prepara- 
tions and observed for leukemia development and regression (Table IX). SFFV 
rescued by MuLV-RF caused erythroleukemia, and in 55% of the leukemic mice 
the disease spontaneously regressed. A lower incidence of  regression occurred in 
mice given the other NB-tropic pseudotype, while regression did not occur at all 
in mice inoculated with SFFV rescued by N-tropic MuLV-F. 602  REGRESSION  OF  ERYTHROLEUKEMIA 
TABLE IX 
Properties  of MuL V-F Pseudotypes of SFFV 
Cell-free supernates of 
spleens from mice inocu- 
lated with 
No. erythro-  XC plaque assay 
leukemic 
No  lnocu- 
n/n*  n/b 
lated 
Acqmred 
tropism* 
b/b 
No. re- 
gressed§ 
No  leu- 
kemic 
FV-B +  MuLV-RF-NB  II  15/15¶  4.1"*  3.8  4 3  NB  14/27 
FV-B +  MuLV-FV-NB  15/15  3 5  3 2  3 5  NB  2/15 
FV-B +  MuLV-F-N  14/14  4 0  2 4  2 5  N  0/23 
FV-B  0/1055  <1 099  <1 0  5 2  B 
* Fv-1  type of test cells 
$ As determined by XC plaque titration. 
9 As determined m  Swlss/ICR mice 
~ Tropmm of MuLV 
¶ By day 12 in each group 
** Tlter given in -log~. PFU/ml 
$~ After 180 days. 
99 Titer of stock FV-B 
Discussion 
These studies indicate that the helper MuLV component of RFV is responsible 
for the spontaneous regression of the leukemia that the RFV induces. 
RFV differs from conventional strains of FV in tropism, a property controlled 
by the helper MuLV in the virus complex. FV can be induced to change tropism 
by forced passage through Fv-1 incompatible (Swiss/ICR) hosts. When this was 
done, CFV, originally N-tropic, became NB-tropic, and the leukemia induced by 
the virus spontaneously regressed.  With one exception, all other FV's which 
induce a regressing leukemia are NB-tropic (27-29). The apparent exception is a 
B-tropic virus inducing a leukemia that regresses (30). 
While our results show a strong relationship between tropism and the regress- 
ing phenotype, we suspect that altered tropism in itself is insufficient to endow 
an FV complex with this property. We have found that several passages of N- 
tropic CFV through BALB/c (Fv-1 ~') mice results in a change in tropism to NB 
without the incidence of significant leukemia regression. After a single passage 
of this virus stock in Fv-1  heterozygous Swiss/ICR mice, the leukemia induced 
by this virus consistently regresses. 
We  have  observed  that  the  change  from induction of a  nonregressing to 
regressing disease is acquired during passage in Swiss/ICR and is maintained 
on back passage in NIH/Swiss Fv-1" mice, reflecting a permanent change in the 
viral genome rather than a reversible modification in the virus. Changes in the 
virus genome which occur on mouse passage might be due to recombinational or 
reassortive events which occur in mice that possess certain gene loci (e.g., Fv- 
1~).  The  tropism  requirement  may reflect the  ability  of NB-tropic  virus  to 
initiate infection and growth in these cells, permitting subsequent modification. 
Using  virus  mixtures we  determined the  effect of altering the  content of 
helper virus in RFV on regression. For this purpose we selected Ri-MuLV which 
causes thymic lymphomas after a long latent period in newborn mice and which 
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The addition of excess Ri-MuLV to RFV inhibited leukemia regression.  The 
inhibition  of regression  could  be  due  to  rescue  of SFFV  by Ri-MuLV.  The 
consequence  of this  rescue  would be  the  formation  of at  least  two  types  of 
viruses,  each with the same SFFV activity but with different MuLV helpers, 
i.e.,  SFFV-(MuLV-RF) and  SFFV-(Ri-MuLV).  If the  Ri-MuLV pseudotype of 
SFFV predominated,  then regression would not occur and its incidence would 
depend on the quantity of competing Ri-MuLV added to RFV. The results of the 
experiments  shown in Table V  demonstrate  that  increasing  quantities  of Ri- 
MuLV  mixed  with  RFV  cause  a  proportional  decrease  in  the  incidence  of 
regression and a proportional increase in the incidence of leukemia. The latter 
observation suggests that Ri-MuLV rescued SFFV. Of interest is that Ri-MuLV 
and MuLV-RF are both NB-tropic. Competition by Ri-MuLV over MuLV-RF for 
SFFV, if successful, would not alter the virus tropism. The fact that regression 
was  inhibited  also  suggests  that  NB-tropism  itself is  not  sufficient to  cause 
regression.  Since immunosuppression inhibits regression (10) it is also possible 
that Ri-MuLV infection might severely disable those immune functions which 
play a  major role in regression and thereby inhibit regression. 
The helper MuLV isolated from RFV by end point dilution passage (MuLV- 
RF), when mixed with CFV, induced erythroleukemia that regressed, confirm- 
ing the results of our earlier mixing experiments (11). Further evidence for the 
determinative  role of MuLV-RF in regression was obtained by examining  the 
specificity of the effect of MuLV-RF on nonregressing leukemia using a variety 
of MuLV-F pseudotypes of SFFV and determining their ability to cause regres- 
sion.  Each of the rescued viruses caused spleen foci and erythroleukemia  and 
therefore contained SFFV. Each of the viruses had acquired the tropism of the 
MuLV-F helper used in rescue, suggesting that these isolates were rescued by 
MuLV-F. It is possible that B to NB conversion was affected simply by passage 
of B tropic FV in Fv-1" mice and not by rescue. However, tropism conversion in a 
single  rescue-passage  method differs from the  conventional  multiple  passage 
methods which result in B to NB conversion (17). Inasmuch as there is no basis 
for expecting N to B or B to N  conversion after a  single passage, other than by 
rescue (17, 31),  we conclude with some certainty that each of these viruses is a 
true  host range  pseudotype of SFFV.  Immunological  evidence of this  can  be 
obtained by determining  whether  each pseudotype has acquired the envelope 
antigens  of the helper MuLV  (31).  Since none of the helper MuLV's from FV 
contained  SFFV activity by spleen focus assay before mixing with FV-B, nor 
could they cause erythroleukemia, the virus recovered from spleens of leukemic 
mice  infected  with  each  pseudotype possessed the  same  SFFV  but  different 
MuLV helper components. 
The pseudotype composed of SFFV and MuLV-RF is NB-tropic and induces 
leukemia that  spontaneously regresses.  Rescue of the same SFFV by another 
NB-tropic MuLV-F, which had been derived by passage of N-tropic MuLV-F in 
BALB/c Fv-lb mice (R. J.  Eckner,  personal communication),  also yielded NB- 
tropic FV which caused leukemia that spontaneously regressed, but at a lower 
incidence. The conversion of FV-B to N tropism by rescue with MuLV-F derived 
from an N-tropic FV complex, yielded an N-tropic FV which induced erythroleu- 
kemia that  did not regress.  Since these studies were carried  out in the same 
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with either of these viruses must be due to the particular helper MuLV of each 
SFFV pseudotype. The capacity of the MuLV-RF pseudotype to induce leukemia 
that  regresses demonstrates  that  the  regressing  phenotype  of RFV is  due to 
MuLV-RF. 
MuLV-RF itself causes lymphocytic leukemia  after a  long  latent  period in 
newborn mice.  The characteristics  of this disease will be detailed in a  subse- 
quent report which will demonstrate that the lymphocytic leukemia induced by 
MuLV-RF itself spontaneously regresses, further supporting the role of MuLV- 
RF as the (viral) determinant  in regression of RFV erythroleukemia. 
Summary 
The RFV strain of the Friend virus complex induces an erythroleukemia that 
spontaneously regresses. The tropism of regressing Friend virus complex (RFV), 
which is conferred by its helper MuLV component, MuLV-RF, is different from 
that of the conventional  virus strain,  CFV.  RFV is NB-tropic and  CFV is N- 
tropic.  Passage  of nonregressing  CFV  through  Fv-1  incompatible  Swiss/ICR 
mice changed the tropism of CFV from N  to NB and resulted in a  virus strain 
which induced erythroleukemia that regressed. Passage of NB-tropic CFV back 
through Fv-1 compatible mice maintained NB-tropism and regression. Altering 
the quantity or type of helper MuLV in RFV complex by addition of Ri-MuLV 
inhibited  regression  in  proportion  to  the  amount  of added  Ri-MuLV.  These 
studies  indicate  a  relationship  between a  change  in  virus tropism  to  NB by 
passage in certain hosts (e.g., Swiss/ICR mice) and the ability of Friend virus to 
induce erythroleukemia that spontaneously regresses. 
MuLV-RF isolated from the RFV complex induced lymphocytic leukemia in 
newborn mice which regressed and caused the regression of CFV-induced eryth- 
roleukemia.  MuLV-RF  is  NB-tropic,  contains  no  spleen  focus-forming  virus 
(SFFV) activity and helps SFFV form spleen foci in genetically restrictive mice. 
Pseudotype viruses were prepared,  consisting of MuLV-RF, or other MuLV's, 
and SFFV derived from FV-B. The pseudotype viruses each acquired the tro- 
pism of the MuLV used in rescue. The pseudotype prepared with MuLV-RF or 
another NB-tropic MuLV-F, but not the virus obtained by rescue with N-tropic 
MuLV-F, induced erythroleukemia that spontaneously regressed. These studies 
demonstrate  that  the  ability of RFV to induce  erythroleukemia  that  sponta- 
neously regresses is due to its helper MuLV component. 
Recewed for pubhcatmn 27 September 1976. 
References 
1.  Friend, C. 1957. Cell-free transmission of a disease having the character of leukemia. 
J. Exp. Med.  105:307. 
2  Dent, P. 1972. Immunodepression by oncogenic viruses. Prog. Med. V~rol  14:1. 
3.  Ceglowski, W. S., and H. Friedman.  1968. Immunosuppressive effects of Friend and 
Rauscher leukemia disease virus on cellular and human antibody formation.  J. Natl 
Cancer Inst. 40:983. 
4.  Rich,  M.  A., R. Siegler,  S.  Karl,  and R.  Clymer.  1969. Spontaneous regression of 
virus induced murine leukemia. I. Host virus system. J. Natl  CancerInst  43:559. 
5.  Rich, M. A., R  Clymer, and S. Karl.  1969. Spontaneous regression of virus induced DIETZ,  FOUCHEY,  LONGLEY,  RICH,  AND  FURMANSKI  605 
murine  leukemia.  II.  Influence  of environmental  factors.  J.  Natl.  Cancer Inst. 
42:571. 
6.  Russo, I., J.  Russo, J.  Baldwin,  and M. A. Rich.  1975. Histopathology of leukemia 
regression. Fed. Proc. 34:869. 
7.  Rich, M. A., and R. Clymer. 1961. Host response in spontaneous regression ofmurine 
leukemia. Cancer Res. 31:803. 
8.  Rich, M. A., S. Karl, and R. Clymer. 1971. Complement fixation in conventional and 
regression virus induced murine leukemia. J. Immunol.  106:1488. 
9.  Cerny,  J.,  M.  Essex,  M.  A.  Rich,  and  W.  D.  Hardy.  1975. Expression  of virus 
associated antigens and immune cell functions during spontaneous regression of the 
Friend viral murine leukemia. Int. J. Cancer. 15:351. 
10.  Dietz, M., P. Furmanski, R. Clymer, and M. A. Rich. 1976. The effects ofthymectomy 
and anti-thymocyte serum on spontaneous regression of Frmnd virus induced eryth- 
roleukemia. J. Natl. Cancer Inst.  57:91. 
11.  Furmanski, P., I. Baldwin, R. Clymer, and M. A. Rich. 1975. Spontaneous regression 
of Friend  virus  induced  leukemia:  coinfection  with  regressing  and  conventional 
stratus of virus. Science (Wash. D. C.).  187:72. 
12.  Eckner, R. J. 1973. Helper dependent properties of Friend spleen focus forming virus: 
effect of the Fv-1 gene on the late stages in virus synthesis. J.  Virol.  12:523. 
13.  Steeves,  R.  A.,  R.  J.  Eckner,  M.  Bennet,  and E.  A.  Mirand.  1971. Isolation and 
characterization of a lymphatic leukemia virus in the Friend virus complex. J. Natl. 
Cancer Inst.  46:1209. 
14.  Steeves,  R. A  1975. Spleen focus forming virus in Friend and Rauscher leukemia 
virus preparahons. J. Natl. Cancer Inst.  54:289. 
15.  Steeves, R.  A.,  R. J  Eckner, E. A.  Mirand, and R. L. Priore.  1971. Rapid assay of 
murine leukemia virus helper activity for Friend spleen focus forming virus. J. Natl. 
Cancer Inst.  46:1219. 
16.  Rich, M. A., J. Geldner, and P. Meyers. 1965. Studies on murine leukemia. J. Natl. 
Cancer Inst.  35:523.  \ 
17.  Lilly, F., and R. A. Steeves. 1973. B-tropic Friend virus: a host-range pseudotype of 
spleen focus forming virus (SFFV).  Virology.  55:363. 
18.  Rowe,  W.  P.,  W.  E.  Pugh,  and J.  W.  Hartley.  1970. Plaque  assay techniques for 
murine leukemia viruses. Virology.  42:1136. 
19  Croker, B. P., B.  C. DeVillano, F.  C. Jensen,  R. A. Lerner, and F. J. Dixon.  1974. 
Immunogenicity and oncogenicity of murine leukemia viruses. I. Induction of immu- 
nologic disease  and  lymphoma in  (BALB/c  x  NZB) F1  mice by Scripps leukemia 
virus. J. Exp. Med.  140:1028. 
20.  Axelrad,  A.,  and  R.  A.  Steeves.  1964. Assay  for  Frmnd  leukemia  virus:  rapid 
quantification  method  based  on  enumeration  of macroscopic spleen  loci  in  mice. 
V~rology.  24:513. 
21.  Lilly, F., and T. Pincus.  1973. Genetic control of murine viral leukemogenesis. Adv. 
Cancer Res.  17:231. 
22.  Steeves, R. A., and F. J. Eckner. 1970. Host-induced changes in infectivity of Friend 
spleen focus forming virus. J. Natl. Cancer Inst. 44:587. 
23.  Rich,  M.  A.,  and  M.  Dietz.  1971. The potential for leukemia regression in  Balb/c 
mice. Proc  Soc. Exp. Biol. Med.  137:35. 
24.  Dawson, P. J., R. B. Tacke, and A. H. Fieldsteel.  1968. Relationship between Friend 
virus and an associated lymphatic leukemia virus. B. J. Cancer. 22:569. 
25.  Eckner,  R.  J.  1975. Continuous  rephcation  of Friend  virus complex (spleen focus- 
forming virus-lymphatic  leukemia  virus-inducing  virus)  in  mouse  embryo fibro- 
blasts. J. Exp. Med.  142:936. 
26.  Scolnick,  E.  M,  R.  J.  Goldbert,  and  D.  Williams.  1976. Characterization  of rat 606  REGRESSION  OF  ERYTHROLEUKEMIA 
genetic sequences of Kirsten sarcoma virus: distinct classes of endogeneous rat type C 
viral sequences.  Virology.  18:559. 
27.  Karnjanaprakorn, C., andS. Thompson. 1973. Development and regression ofmurine 
leukemia induced by Friend virus complex. Proc. Soc. Exp. Biol. Med.  143:300. 
28.  Dawson, P. I., and A. H. Fieldsteel.  1969. Pathogenesis of chronic Friend disease in 
hybrid BDF, mice. Cancer Res. 29:1206. 
29.  Lilly, F. 1968. The effect histocompatibility-2 type on response to the Friend leukemia 
virus in mice. J. Exp. Med.  127:465. 
30.  Chesebro, B., K. Wehrly, and J.  Stimpfling.  1974. Host genetic control of recovery 
from Friend leukemia virus induced splenomegaly. Mapping of a  gene within the 
major histocompatability complex. J. Exp  Med.  140:1457. 
31.  Eckner,  R.  J.,  and  R.  A.  Steeves.  1972. A  classification of the  murine  leukemia 
viruses: neutralization of pseudotypes of Friend spleen focus forming virus by type 
specific murme antisera. J. Exp. Med.  136:832. 